HBMN HBM Healthcare Investments AG Ord

252.79USD213.00 CHF · SWX-2.52%Mkt Cap: 1.63B USDP/E: 4.00

HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late…

Institutional holders7 on file

Key Statistics

Company
Market Cap1.63B USD
Enterprise Value1.86B USD
Revenue (TTM)423.44M USD
Gross Profit423.44M USD
Net Income (TTM)322.63M USD
Revenue/Share64.01 USD
Last Price252.79 USD
Fiscal Year EndMar 2026
MR QuarterSep 2026
Employees—
CountryCH
SectorFinancial Services
IndustryCapital Markets
ISINCH0012627250
Valuation
P/E (Trailing)4.00
P/E (Forward)13.34
PEG—
EV/EBITDA—
EV/Revenue4.39
P/S3.84
P/B0.72
EPS (TTM)63.20 USD
EPS (Forward)18.95 USD
52W Range
235.7024% of range306.19
52W High306.19 USD
52W Low235.70 USD
Profitability
Gross Margin100.00%
Oper. Margin99.30%
EBITDA Margin0.00%
Profit Margin99.06%
ROE14.74%
ROA13.96%
ROIC—
ROCE—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.77M USD
CapEx (TTM)—
FCF Margin62.36%
FCF Yield16.23%
Net Debt202.44M USD
Net Debt/EBITDA—
Net Debt/FCF0.77
Balance Sheet
Debt/Equity0.05
Current Ratio0.06
Quick Ratio0.06
Book Value/Sh352.83 USD
Cash/Share2.04 USD
Dividends
Fwd Div Rate10.68 USD
Trail. Div Rate10.68 USD
Div. Yield4.12%
5Y Avg Yield4.09%
Payout Ratio16.90%
Ex-Div DateJun 17, 2026
Pay DateAug 9, 2024
Analyst Consensus
Rating—
Target (Mean)332.30 USD
Upside (mean)+31.5%
Target Range332.30 USD – 332.30 USD
# Analysts1
Ownership
Shares Out.6.44M
Float4.95M
Insiders16.58%
Institutions10.48%
Technical
SMA 50271.42 (-6.9%)
SMA 200275.50 (-8.2%)
Beta0.76
S&P 52W Chg8.68%
Avg Vol (30d)5.97K
Avg Vol (10d)5.78K
Technical Indicators
RSI (14)30.6
MACD-2.7062
MACD Signal-2.1672
MACD Hist.-0.5390
BB Upper273.79 USD
BB Middle264.83 USD
BB Lower255.87 USD
BB Width6.76%
ATR (14)5.808 USD
Vol Ratio (20d)0.82x

About HBM Healthcare Investments AG Ord (SWX: HBMN)

›

HBM Healthcare Investments AG Ord (SWX: HBMN) is listed on the SIX Swiss Exchange, where its shares trade in CHF. It belongs to the Capital Markets industry, part of the Financial Services sector.

The shares were at 213.00 CHF on 20 November 2026, up 6.6% over 52 weeks. Its 52-week range is 198.60 CHF to 258.00 CHF: the price is 17.4% below the high and 7.3% above the low.

At a market capitalisation of 1.37B CHF, it trades at 4.0 times trailing earnings and 13.3 times forward earnings. The median trailing P/E of its 20 largest Capital Markets peers is 15.0, a discount of 73% for HBMN. It pays a dividend yielding 4.12% (it pays out 17% of its earnings), against a median of 2.01% among the dividend payers in that peer group.

HBM Healthcare Investments AG Ord reports return on equity of 14.7% and an operating margin of 99.3%.

Its debt exceeds its cash by 170.58M CHF, a debt-to-equity ratio of 0.05. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 280.00 CHF is 31.5% above the current price. The next earnings report is expected on 22 January 2027.